hDMT partner Minacned

About hDMT

The Institute for human Organ and Disease Model technologies (hDMT) is a precompetitive non-profit technological R&D institute, initiated in the Netherlands. hDMT integrates state-of-the-art human stem cell technologies with top level engineering, physics, chemistry, biology, clinical and pharmaceutical expertise from academia and industry to develop and valorize human organ and disease models-on-a-chip.

Human test model systems

These miniature models in chip format closely mimic human tissue and organs in vivo. This will primarily meet the need for representative human test model systems for drug development and other applications, and as an additional goal also will reduce the use of animal experiments. hDMT will engage in close dialogue with pharmaceutical and other companies to tune the scientific program to their needs for specific organ and disease models. Within the hDMT Institute also the ‘scalability and manufacturability’ of the technologies will be addressed.

Virtual institute

hDMT combines technologies, facilities and expertise from different disciplines and multiple organizations and locations, thereby forming a virtual institute, ‘a laboratory without walls’. hDMT is a public-private consortium of 9 founding partners, including the three Universities of Technology (Twente, Eindhoven, Delft), the Leiden University and University Medical Centre, Erasmus Medical Centre, the Hubrecht Institute, and two companies Genmab and Galapagos. As a central point of contact hDMT is envisaged as the gateway for pharmaceutical companies to ‘Organ on chip’ technology in the Netherlands, supported by world class stem cell science. hDMT will consolidate expertise in the Netherlands and collaborate with experts from abroad in this area to develop complementary international programs that will lead to new insights in human disease, and to new treatments and diagnostic tests.

Contact

hDMT
If you have any practical questions regarding hDMT, please send an e-mail: info@hdmt.technology.
For all other questions contact Managing Director Janny van den Eijnden – van Raaij: j.vandeneijnden@hdmt.technology or call +31(0)6 1299 8074.

Gepubliceerde artikelen

RAAK MKB Indieningsronde maart 2021

Op deze pagina vind je in het kort de belangrijkste informatie…
14 januari 2021/door Aurélie Veltema

DSM en TU Delft realiseren laboratorium voor kunstmatige intelligentie als stimulans voor biowetenschappelijke innovatie

Koninklijke DSM, een wereldwijd bedrijf dat vanuit wetenschappelijke…
14 januari 2021/door Aurélie Veltema

MinacNed pre-events in 2021: We hebben uw input nodig

In 2021 gaat het MinacNed team door met organiseren van de iMNC-pre-events,…
13 januari 2021/door Aurélie Veltema

QuTech, KPN, SURF en OPNT bouwen samen aan quantumnetwerk

QuTech (een samenwerking tussen TU Delft en TNO), KPN, SURF en…
11 januari 2021/door Aurélie Veltema

MinacNed members showcase their company in promotional video

To showcase the partners in the nanotechnology ecosytem, MinacNed…
6 januari 2021/door Aurélie Veltema

Key Technologies pre-registration call

Consortia including research institutes and public and private…
9 december 2020/door Aurélie Veltema

Venture Challenge: Registration open for new edition

From this week onwards, starting entrepreneurs in the…
8 december 2020/door Aurélie Veltema

Open platform technologies can give medical start-ups a boost

The medical market can learn a thing from the consumer electronics…
1 december 2020/door Aurélie Veltema

13 New SME-deals for regional support of SME’s

With 13 new SME deals, the Ministry of Economic Affairs and Climate…
26 november 2020/door Aurélie Veltema

Highlights in the iMNC2020-program according to Maarten Honing

By Dimitri Reijerman, FHI

Because of the corona pandemic,…
25 november 2020/door Aurélie Veltema

16th edition of the International MicroNanoConference 2020 fully digital

On 3 and 4 December 2020, MinacNed, in collaboration with its…
20 november 2020/door Aurélie Veltema

Doe een voorstel voor een innovatieve oplossing voor de vaccinatielogistiek!

Er wordt hard gewerkt aan vaccins die we begin volgend jaar verwachten.…
19 november 2020/door Aurélie Veltema